Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Addison's Disease Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Addison's Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Oral Corticosteroid 1.4.3 Corticosteroid Injections 1.5 Market by Application 1.5.1 Global Addison's Disease Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Addison's Disease Treatment Market Perspective (2015-2026) 2.2 Addison's Disease Treatment Growth Trends by Regions 2.2.1 Addison's Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Addison's Disease Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Addison's Disease Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Addison's Disease Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Addison's Disease Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Addison's Disease Treatment Players by Market Size 3.1.1 Global Top Addison's Disease Treatment Players by Revenue (2015-2020) 3.1.2 Global Addison's Disease Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Addison's Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Addison's Disease Treatment Market Concentration Ratio 3.2.1 Global Addison's Disease Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Addison's Disease Treatment Revenue in 2019 3.3 Addison's Disease Treatment Key Players Head office and Area Served 3.4 Key Players Addison's Disease Treatment Product Solution and Service 3.5 Date of Enter into Addison's Disease Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Addison's Disease Treatment Historic Market Size by Type (2015-2020) 4.2 Global Addison's Disease Treatment Forecasted Market Size by Type (2021-2026) 5 Addison's Disease Treatment Breakdown Data by Application (2015-2026) 5.1 Global Addison's Disease Treatment Market Size by Application (2015-2020) 5.2 Global Addison's Disease Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Addison's Disease Treatment Market Size (2015-2020) 6.2 Addison's Disease Treatment Key Players in North America (2019-2020) 6.3 North America Addison's Disease Treatment Market Size by Type (2015-2020) 6.4 North America Addison's Disease Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Addison's Disease Treatment Market Size (2015-2020) 7.2 Addison's Disease Treatment Key Players in Europe (2019-2020) 7.3 Europe Addison's Disease Treatment Market Size by Type (2015-2020) 7.4 Europe Addison's Disease Treatment Market Size by Application (2015-2020) 8 China 8.1 China Addison's Disease Treatment Market Size (2015-2020) 8.2 Addison's Disease Treatment Key Players in China (2019-2020) 8.3 China Addison's Disease Treatment Market Size by Type (2015-2020) 8.4 China Addison's Disease Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Addison's Disease Treatment Market Size (2015-2020) 9.2 Addison's Disease Treatment Key Players in Japan (2019-2020) 9.3 Japan Addison's Disease Treatment Market Size by Type (2015-2020) 9.4 Japan Addison's Disease Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Addison's Disease Treatment Market Size (2015-2020) 10.2 Addison's Disease Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Addison's Disease Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Addison's Disease Treatment Market Size by Application (2015-2020) 11 India 11.1 India Addison's Disease Treatment Market Size (2015-2020) 11.2 Addison's Disease Treatment Key Players in India (2019-2020) 11.3 India Addison's Disease Treatment Market Size by Type (2015-2020) 11.4 India Addison's Disease Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Addison's Disease Treatment Market Size (2015-2020) 12.2 Addison's Disease Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Addison's Disease Treatment Market Size by Type (2015-2020) 12.4 Central & South America Addison's Disease Treatment Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Pfizer 13.1.1 Pfizer Company Details 13.1.2 Pfizer Business Overview and Its Total Revenue 13.1.3 Pfizer Addison's Disease Treatment Introduction 13.1.4 Pfizer Revenue in Addison's Disease Treatment Business (2015-2020)) 13.1.5 Pfizer Recent Development 13.2 GlaxoSmithKline 13.2.1 GlaxoSmithKline Company Details 13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue 13.2.3 GlaxoSmithKline Addison's Disease Treatment Introduction 13.2.4 GlaxoSmithKline Revenue in Addison's Disease Treatment Business (2015-2020) 13.2.5 GlaxoSmithKline Recent Development 13.3 Takeda 13.3.1 Takeda Company Details 13.3.2 Takeda Business Overview and Its Total Revenue 13.3.3 Takeda Addison's Disease Treatment Introduction 13.3.4 Takeda Revenue in Addison's Disease Treatment Business (2015-2020) 13.3.5 Takeda Recent Development 13.4 Abbott Laboratories 13.4.1 Abbott Laboratories Company Details 13.4.2 Abbott Laboratories Business Overview and Its Total Revenue 13.4.3 Abbott Laboratories Addison's Disease Treatment Introduction 13.4.4 Abbott Laboratories Revenue in Addison's Disease Treatment Business (2015-2020) 13.4.5 Abbott Laboratories Recent Development 13.5 Merck 13.5.1 Merck Company Details 13.5.2 Merck Business Overview and Its Total Revenue 13.5.3 Merck Addison's Disease Treatment Introduction 13.5.4 Merck Revenue in Addison's Disease Treatment Business (2015-2020) 13.5.5 Merck Recent Development 13.6 Boehringer Ingelheim 13.6.1 Boehringer Ingelheim Company Details 13.6.2 Boehringer Ingelheim Business Overview and Its Total Revenue 13.6.3 Boehringer Ingelheim Addison's Disease Treatment Introduction 13.6.4 Boehringer Ingelheim Revenue in Addison's Disease Treatment Business (2015-2020) 13.6.5 Boehringer Ingelheim Recent Development 13.7 Amgen 13.7.1 Amgen Company Details 13.7.2 Amgen Business Overview and Its Total Revenue 13.7.3 Amgen Addison's Disease Treatment Introduction 13.7.4 Amgen Revenue in Addison's Disease Treatment Business (2015-2020) 13.7.5 Amgen Recent Development 13.8 Lupin Pharmaceuticals 13.8.1 Lupin Pharmaceuticals Company Details 13.8.2 Lupin Pharmaceuticals Business Overview and Its Total Revenue 13.8.3 Lupin Pharmaceuticals Addison's Disease Treatment Introduction 13.8.4 Lupin Pharmaceuticals Revenue in Addison's Disease Treatment Business (2015-2020) 13.8.5 Lupin Pharmaceuticals Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Addison's Disease Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Addison's Disease Treatment Revenue Table 3. Ranking of Global Top Addison's Disease Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Addison's Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Oral Corticosteroid Table 6. Key Players of Corticosteroid Injections Table 7. Global Addison's Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Addison's Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Addison's Disease Treatment Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Addison's Disease Treatment Market Share by Regions (2015-2020) Table 11. Global Addison's Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Addison's Disease Treatment Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Addison's Disease Treatment Market Growth Strategy Table 17. Main Points Interviewed from Key Addison's Disease Treatment Players Table 18. Global Addison's Disease Treatment Revenue by Players (2015-2020) (Million US$) Table 19. Global Addison's Disease Treatment Market Share by Players (2015-2020) Table 20. Global Top Addison's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addison's Disease Treatment as of 2019) Table 21. Global Addison's Disease Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Addison's Disease Treatment Product Solution and Service Table 24. Date of Enter into Addison's Disease Treatment Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 27. Global Addison's Disease Treatment Market Size Share by Type (2015-2020) Table 28. Global Addison's Disease Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Addison's Disease Treatment Market Size Share by Application (2015-2020) Table 30. Global Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 31. Global Addison's Disease Treatment Market Size Share by Application (2021-2026) Table 32. North America Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$) Table 33. North America Key Players Addison's Disease Treatment Market Share (2019-2020) Table 34. North America Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 35. North America Addison's Disease Treatment Market Share by Type (2015-2020) Table 36. North America Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 37. North America Addison's Disease Treatment Market Share by Application (2015-2020) Table 38. Europe Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Addison's Disease Treatment Market Share (2019-2020) Table 40. Europe Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 41. Europe Addison's Disease Treatment Market Share by Type (2015-2020) Table 42. Europe Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 43. Europe Addison's Disease Treatment Market Share by Application (2015-2020) Table 44. China Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$) Table 45. China Key Players Addison's Disease Treatment Market Share (2019-2020) Table 46. China Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 47. China Addison's Disease Treatment Market Share by Type (2015-2020) Table 48. China Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 49. China Addison's Disease Treatment Market Share by Application (2015-2020) Table 50. Japan Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Addison's Disease Treatment Market Share (2019-2020) Table 52. Japan Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 53. Japan Addison's Disease Treatment Market Share by Type (2015-2020) Table 54. Japan Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 55. Japan Addison's Disease Treatment Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Addison's Disease Treatment Market Share (2019-2020) Table 58. Southeast Asia Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Addison's Disease Treatment Market Share by Type (2015-2020) Table 60. Southeast Asia Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Addison's Disease Treatment Market Share by Application (2015-2020) Table 62. India Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$) Table 63. India Key Players Addison's Disease Treatment Market Share (2019-2020) Table 64. India Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 65. India Addison's Disease Treatment Market Share by Type (2015-2020) Table 66. India Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 67. India Addison's Disease Treatment Market Share by Application (2015-2020) Table 68. Central & South America Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Addison's Disease Treatment Market Share (2019-2020) Table 70. Central & South America Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Addison's Disease Treatment Market Share by Type (2015-2020) Table 72. Central & South America Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Addison's Disease Treatment Market Share by Application (2015-2020) Table 74. Pfizer Company Details Table 75. Pfizer Business Overview Table 76. Pfizer Product Table 77. Pfizer Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$) Table 78. Pfizer Recent Development Table 79. GlaxoSmithKline Company Details Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline Product Table 82. GlaxoSmithKline Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$) Table 83. GlaxoSmithKline Recent Development Table 84. Takeda Company Details Table 85. Takeda Business Overview Table 86. Takeda Product Table 87. Takeda Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$) Table 88. Takeda Recent Development Table 89. Abbott Laboratories Company Details Table 90. Abbott Laboratories Business Overview Table 91. Abbott Laboratories Product Table 92. Abbott Laboratories Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$) Table 93. Abbott Laboratories Recent Development Table 94. Merck Company Details Table 95. Merck Business Overview Table 96. Merck Product Table 97. Merck Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$) Table 98. Merck Recent Development Table 99. Boehringer Ingelheim Company Details Table 100. Boehringer Ingelheim Business Overview Table 101. Boehringer Ingelheim Product Table 102. Boehringer Ingelheim Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$) Table 103. Boehringer Ingelheim Recent Development Table 104. Amgen Company Details Table 105. Amgen Business Overview Table 106. Amgen Product Table 107. Amgen Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$) Table 108. Amgen Recent Development Table 109. Lupin Pharmaceuticals Business Overview Table 110. Lupin Pharmaceuticals Product Table 111. Lupin Pharmaceuticals Company Details Table 112. Lupin Pharmaceuticals Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$) Table 113. Lupin Pharmaceuticals Recent Development Table 114. Research Programs/Design for This Report Table 115. Key Data Information from Secondary Sources Table 116. Key Data Information from Primary Sources List of Figures Figure 1. Global Addison's Disease Treatment Market Share by Type: 2020 VS 2026 Figure 2. Oral Corticosteroid Features Figure 3. Corticosteroid Injections Features Figure 4. Global Addison's Disease Treatment Market Share by Application: 2020 VS 2026 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Others Case Studies Figure 8. Addison's Disease Treatment Report Years Considered Figure 9. Global Addison's Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Addison's Disease Treatment Market Share by Regions: 2020 VS 2026 Figure 11. Global Addison's Disease Treatment Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Addison's Disease Treatment Market Share by Players in 2019 Figure 14. Global Top Addison's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addison's Disease Treatment as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Addison's Disease Treatment Revenue in 2019 Figure 16. North America Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Pfizer Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020) Figure 25. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. GlaxoSmithKline Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020) Figure 27. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Takeda Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020) Figure 29. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Abbott Laboratories Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020) Figure 31. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Merck Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020) Figure 33. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Boehringer Ingelheim Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020) Figure 35. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Amgen Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020) Figure 37. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Lupin Pharmaceuticals Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020) Figure 39. Bottom-up and Top-down Approaches for This Report Figure 40. Data Triangulation Figure 41. Key Executives Interviewed

Pfizer GlaxoSmithKline Takeda Abbott Laboratories Merck Boehringer Ingelheim Amgen Lupin Pharmaceuticals